Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations

被引:75
作者
Barrow, E.
Alduaij, W.
Robinson, L.
Shenton, A.
Clancy, T.
Lalloo, F.
Hill, J.
Evans, D. G.
机构
[1] Cent Manchester & Manchester Childrens Univ Hosp, Manchester, Lancs, England
[2] Univ Manchester, St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England
[3] Univ Manchester, St Marys Hosp, Med Genet Res Grp, Manchester M13 0JH, Lancs, England
[4] Manchester Royal Infirm, Dept Gen Surg, Manchester M13 9WL, Lancs, England
关键词
colorectal neoplasms; DNA mismatch repair; hereditary non-polyposis colorectal cancer; Kaplan-Meier analysis; statistical bias;
D O I
10.1111/j.1399-0004.2008.01035.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant condition caused by inactivating mutations of DNA mismatch repair (MMR) genes. An accurate estimation of colorectal cancer risk for mutation carriers is essential for counselling and rationalizing screening programmes. Families were referred on the basis of clinical criteria. Tumour immunohistochemistry and microsatellite testing were performed. Appropriate patients underwent sequencing of all relevant exons of the MMR genes. Proven and obligate mutation carriers and first-degree relatives (FDRs) with an HNPCC spectrum cancer were considered mutation carriers, as were a proportion of untested, unaffected FDRs based on the proportion of unaffected relatives testing positive in each age group. The cumulative lifetime risk was calculated by Kaplan-Meier analysis. Three hundred and forty-one colorectal cancers in 839 proven, obligate, or assumed mutation carriers were analysed. The cumulative risk to age 70 years for all mutation carriers combined was 50.4% (95% CI 47.8-52.9). The cumulative risk in males was 54.3% (95% CI 50.7-57.8), which was significantly higher than in females (log rank p = 0.02) who had a risk of 46.3% (95% CI 42.8-49.9). These penetrance estimates from HNPCC families attending high-risk clinics have been corrected for ascertainment bias and are appropriate risks for those referred to a high-risk clinic. Current colonoscopic screening guidelines are appropriate.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 29 条
[1]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[2]  
2-C
[3]   Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [J].
Aarnio, M ;
Mecklin, JP ;
Aaltonen, LA ;
NystromLahti, M ;
Jarvinen, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) :430-433
[4]   Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer [J].
Barnetson, Rebecca A. ;
Tenesa, Albert ;
Farrington, Susan M. ;
Nicholl, Iain D. ;
Cetnarskyj, Roseanne ;
Porteous, Mary E. ;
Campbell, Harry ;
Dunlop, Malcolm G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26) :2751-2763
[5]  
Bertario L, 1999, INT J CANCER, V80, P183, DOI 10.1002/(SICI)1097-0215(19990118)80:2<183::AID-IJC4>3.0.CO
[6]  
2-W
[7]   Hereditary non-polyposis colorectal cancer:: current risks of colorectal cancer largely overestimated [J].
Carayol, J ;
Khlat, M ;
Maccario, J ;
Bonaïti-Pellié, C .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) :335-339
[8]   Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome [J].
Dunlop, MG .
GUT, 2002, 51 :V21-V27
[9]   Cancer risk associated with germline DNA mismatch repair gene mutations [J].
Dunlop, MG ;
Farrington, SM ;
Carothers, AD ;
Wyllie, AH ;
Sharp, L ;
Burn, J ;
Liu, B ;
Kinzler, KW ;
Vogelstein, B .
HUMAN MOLECULAR GENETICS, 1997, 6 (01) :105-110
[10]   Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset [J].
Hampel, H ;
Stephens, JA ;
Pukkala, E ;
Sankila, R ;
Aaltonen, LA ;
Mecklin, JP ;
de la Chapelle, A .
GASTROENTEROLOGY, 2005, 129 (02) :415-421